Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2022 and the Full Year Ending March 31, 2023
August 01, 2022 at 10:30 am IST
Share
Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the six months ending September 30, 2022 and the full year ending March 31, 2023. For the six months ending September 30, 2022, the company expects a net sales of ¥4,170 million, Operating profit of ¥520 million, and Profit of ¥360 million or ¥12.53 per share.
For the year ending March 31, 2023, the company expects a net sales of ¥8,750 million, Operating profit of ¥1,200 million, and Profit of ¥840 million or ¥29.24 per share.
DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Companyâs products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2022 and the Full Year Ending March 31, 2023
DAIKEN MEDICAL CO., LTD. 